HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

João T Barata Selected Research

Carcinogenesis

12/2019MicroRNAs and their involvement in T-ALL: A brief overview.
10/2010Targeting CK2 overexpression and hyperactivation as a novel therapeutic tool in chronic lymphocytic leukemia.
8/2007Expression and subcellular localization of a novel nuclear acetylcholinesterase protein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


João T Barata Research Topics

Disease

26Leukemia
01/2023 - 05/2009
21Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
12/2023 - 04/2010
21Neoplasms (Cancer)
01/2023 - 05/2009
18Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2023 - 04/2010
3Lymphoma (Lymphomas)
01/2020 - 03/2010
3Carcinogenesis
12/2019 - 08/2007
2Lymphoid Leukemia
01/2023 - 01/2019
2Brain Neoplasms (Brain Tumor)
01/2023 - 01/2022
2Neoplasm Metastasis (Metastasis)
01/2023 - 01/2022
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2014 - 10/2011
1Brain Diseases (Brain Disorder)
01/2023
1COVID-19
01/2023
1Typical Teratoid Rhabdoid Tumor
01/2022
1Thymus Hyperplasia
01/2021
1Hematologic Neoplasms (Hematological Malignancy)
01/2020
1Residual Neoplasm
01/2020
1B-Cell Lymphoma (Lymphoma, B Cell)
11/2016
1Thymoma (Thymic Carcinoma)
11/2016
1Disease Progression
01/2016
1Adenocarcinoma
02/2015
1T-Cell Leukemia (Leukemia, T Cell)
07/2011

Drug/Important Bio-Agent (IBA)

16Interleukin-7 (Interleukin 7)IBA
01/2023 - 07/2011
6Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2007
5Interleukin-7 Receptors (Interleukin 7 Receptor)IBA
01/2023 - 07/2011
4Phosphotransferases (Kinase)IBA
01/2022 - 06/2014
4CytokinesIBA
05/2020 - 07/2011
4Phosphoric Monoester Hydrolases (Phosphatases)IBA
05/2020 - 01/2014
4Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
05/2020 - 11/2016
3Protein Isoforms (Isoforms)IBA
12/2023 - 08/2007
3TensinsIBA
05/2020 - 01/2014
3Casein Kinase II (Casein Kinase 2)IBA
05/2020 - 10/2010
3MicroRNAs (MicroRNA)IBA
12/2019 - 01/2016
2T-Cell Acute Lymphocytic Leukemia Protein 1IBA
12/2023 - 02/2016
2dactolisibIBA
01/2023 - 01/2021
2RNA (Ribonucleic Acid)IBA
01/2023 - 11/2018
2Peptides (Polypeptides)IBA
05/2020 - 01/2014
2CIGB-300IBA
05/2020 - 01/2014
2GlucocorticoidsIBA
01/2020 - 03/2018
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2019 - 05/2009
2Dexamethasone (Maxidex)FDA LinkGeneric
01/2019 - 03/2018
2Sirolimus (Rapamycin)FDA Link
11/2018 - 04/2011
2Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
11/2018 - 10/2011
2LipidsIBA
02/2015 - 06/2014
2PTEN Phosphohydrolase (PTEN Phosphatase)IBA
06/2014 - 04/2010
2Amyloid Precursor Protein Secretases (beta-Secretase)IBA
09/2011 - 04/2010
2AntigensIBA
08/2010 - 05/2009
2Biomarkers (Surrogate Marker)IBA
08/2010 - 03/2010
1Lactate Dehydrogenase 5IBA
01/2022
1ruxolitinibIBA
01/2021
1venetoclaxIBA
01/2021
1palbociclibIBA
01/2021
1AZD1208IBA
01/2021
1Tetracycline (Achromycin)FDA LinkGeneric
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1NucleophosminIBA
05/2020
1Janus KinasesIBA
05/2020
1Lymphoid Enhancer-Binding Factor 1IBA
01/2020
1Immunoconjugates (Immunoconjugate)IBA
01/2019
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
11/2018
1ChromatinIBA
11/2018
1STAT5 Transcription FactorIBA
11/2016
1Protein Kinases (Protein Kinase)IBA
11/2016
1Transcription Factors (Transcription Factor)IBA
01/2016
1Lymphotoxin-alpha (Lymphotoxin)IBA
12/2015
1Adenosine Monophosphate (AMP)IBA
02/2015
1human neutrophil peptide 1IBA
02/2015
1silmitasertibIBA
06/2014
1DisulfidesIBA
05/2013
1Therapeutic UsesIBA
07/2011
1Ribosomal Proteins (Ribosomal Protein)IBA
04/2011
1TOR Serine-Threonine KinasesIBA
04/2011
1Eukaryotic Initiation Factor-4G (Eukaryotic Initiation Factor 4G)IBA
04/2011
1Cyclin-Dependent Kinase Inhibitor p27IBA
04/2011
1temsirolimusFDA Link
04/2011
1Membrane Proteins (Integral Membrane Proteins)IBA
08/2010
1Complementary DNA (cDNA)IBA
08/2010
1Gamma Secretase Inhibitors and ModulatorsIBA
04/2010
1Dichlororibofuranosylbenzimidazole (DRB)IBA
04/2010
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
04/2010
1HLA Antigens (Human Leukocyte Antigens)IBA
03/2010
1prenylIBA
05/2009
1diphosphoric acid (pyrophosphoric acid)IBA
05/2009
14-hydroxy-3-methyl-2-butenyl diphosphateIBA
05/2009
14-hydroxy-3-methylbut-2-enyl pyrophosphateIBA
05/2009
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2007

Therapy/Procedure

8Therapeutics
01/2023 - 10/2011
5Drug Therapy (Chemotherapy)
12/2023 - 09/2014
4Immunotherapy
05/2013 - 05/2009
2Transplantation
01/2021 - 05/2009
1Cell Transplantation
01/2022
1Induction Chemotherapy
01/2020
1Combination Drug Therapy (Combination Chemotherapy)
03/2018
1Heterologous Transplantation (Xenotransplantation)
07/2014